Autolus Therapeutics plc Construction in Progress, Gross
Autolus Therapeutics plc (AUTL) had Construction in Progress, Gross of $800.00 thousand as of 2019-06-30, per its 6-K filed 2019-08-08.
Discontinued › Balance Sheet › Assets › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:ConstructionInProgressGross · last filed 2019-11-07
- 2019-06-30: Construction in Progress, Gross $800.00K.
- 2018-12-31: Construction in Progress, Gross $6.60M.
| Period end | Construction in Progress, Gross |
|---|---|
| 2019-06-30 | $800.00K 6-K · filed 2019-08-08 |
| 2018-12-31 | $6.60M 6-K · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 |